Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company...
New and proposed FDA regulations could create new
opportunities for pharmaceutical companies looking to develop digital tools,
according to a new PricewaterhouseCoopers (PwC) report.
Within the last...